Filgotinib for treating moderately to severely active ulcerative colitis

Equality Impact Assessment (Guidance development) (PDF 141 KB)

Final draft guidance

Final appraisal document (PDF 242 KB)

Committee papers (PDF 9.04 MB)

Public committee slides (PDF 1.79 MB)

Final scope (PDF 184 KB)

Final stakeholder list (PDF 177 KB)

Draft scope and provisional stakeholder list comments table (post-referral) (PDF 231 KB)

Equality impact assessment (Scoping) (PDF 122 KB)

Draft scope post referral (PDF 198 KB)

Draft matrix post referral (PDF 176 KB)